Amiko: Amiko announces strategic investment from Sanner, gets CE mark for Respiro platform

Sanner Ventures and Amiko Digital Health have announced a deal in which Sanner will make a strategic investment in further development of Amiko's Respiro dry powder inhaler monitoring platform. Amiko also announced that the Respiro platform has received the CE mark for use with the Spiromax, Nexthaler, and Ellipta inhalers. According to Amiko, the company [...]